News tagged ‘BasicResearch’ clear
- Edward J. Benz, Jr., MD, offers his thoughts on the introduction of the
21st Century Cancer Access to Life-Saving Early detection, Research and
Treatment (ALERT) Act.
Tags: BasicResearch, Prevention
- Dana-Farber Cancer Institute researchers have isolated a new type of energy-burning fat cell called "beige fat" in adult humans which they say may have therapeutic potential for treating obesity.
- David Steensma, MD, leads Dana-Farber's efforts as part of a six-institution, $16 million research consortium advancing the treatments and outcomes for patients suffering from Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood.
- David Pellman, MD, a pediatric oncologist at Dana-Farber and
Children's Hospital Boston, is one of 56 scientists just selected as an
investigator of the Howard Hughes Medical Institute, a non-profit
medical research organization that ranks as one of the nation's largest
Tags: BasicResearch, ChildhoodCancer
- Testifying today at a U.S. Senate Committee hearing on federal priorities for the fight against cancer, Dana-Farber President Edward J. Benz, Jr., MD, urged legislators to view cancer research through the widest possible prism.
Tags: BasicResearch, Grants
- The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), recently announced grants expected to total approximately $30 million to establish a new Center of Excellence in Genomic Science at Dana-Farber Cancer Institute and continue its support of the center at Stanford University.
Tags: BasicResearch, Genomics
- "Beige" fat cells found in healthy subcutaneous fat play a critical role in protecting the body against the disease risks of obesity in mice, report researchers at Dana-Farber Cancer Institute, who say their study findings may have implications for therapy of obesity-related illness in humans.
- Dana-Farber and Brigham and Women's Hospital have launched Profile, one of the most comprehensive cancer research studies to help accelerate the development of personalized treatments for every person with cancer.
Tags: BasicResearch, Genomics, TargetedTherapy, Genetics
- In an effort to improve the success rate of investigational
cancer drugs entering clinical trials, the Center for Applied Cancer
Science (CACS) of the Dana-Farber Cancer Institute and Merck and Co.,
Inc., have established a collaboration to identify promising drug
targets, and develop therapeutic candidates to reach those targets.
- Genetic specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) are recommending that children being treated for sarcoma should be offered genetic counseling for Li-Fraumeni syndrome, a rare condition that greatly raises a person’s risk of developing additional cancers
Tags: BasicResearch, Genomics, Sarcoma
Showing 21-30 of 110 items